Search - tctmd.com

Displaying 61 - 80 of 227

Sort: Relevancy | Date

News Industry News

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

October 22, 2015

Presentation TCT 2015

Heart Block at Day 3 After Alcohol Septal Ablation. What to Do Now?

Presenter: Dominique Himbert, Paul Sorajja, John C. Messenger

October 15, 2015

Presentation TCT 2015

Alcohol Septal Ablation: My Worst Complication (and What I Wish I Did Differently)

Presenter: Dominique Himbert, Paul Sorajja, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

Who to Restrict for Athletic Participation

Presenter: Dominique Himbert, Paul Sorajja

October 15, 2015

Presentation TCT 2015

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Should Be Offered to Elderly Patients Only!

Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr

October 15, 2015

Presentation TCT 2015

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Is Equally Effective at All Ages!

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 15, 2015

Presentation TCT 2015

Alcohol Septal Ablation Is the Choice for Most Cases!

Presenter: Srihari S. Naidu, Paul Sorajja

October 15, 2015

Presentation TCT 2015

Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? No, It Does Not!

Presenter: Srihari S. Naidu, Paul Sorajja

October 15, 2015

Presentation TCT 2015

Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? Yes, Definitely!

Presenter: Srihari S. Naidu, Paul Sorajja, Valerian Fernandes

October 15, 2015

Presentation TCT 2015

HCM Ablation Step-by-Step Approach, Complications, and Long-term Outcomes

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Valerian Fernandes

October 15, 2015

Presentation TCT 2015

CTA for Procedure Planning

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Jorge Gaspar

October 15, 2015

Presentation TCT 2015

Indications for Septal Reduction Therapy

Presenter: John S. Douglas Jr, Sherif F. Nagueh

October 15, 2015

Presentation TCT 2015

Medical Management: Agents and Effectiveness

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid

October 15, 2015

Presentation TCT 2015

Pathophysiology and Natural History

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Mark V. Sherrid

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

Presentation TCT 2015

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

Presenter: Andrea Abizaid, Daniel Burkhoff, Salvatore Brugaletta

October 14, 2015

Presentation TCT 2015

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Presenter: David P. Faxon, David O. Williams, Martin W Bergmann

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

Presentation TCT 2015

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case

Presenter: D. Craig Miller, Alec S. Vahanian, Jan Kovac

October 12, 2015

Presentation TCT 2015

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation

Presenter: D. Craig Miller, Alec S. Vahanian, Mayra Guerrero

October 12, 2015

Advertisement

Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure

Heart Block at Day 3 After Alcohol Septal Ablation. What to Do Now?

Alcohol Septal Ablation: My Worst Complication (and What I Wish I Did Differently)

Who to Restrict for Athletic Participation

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Should Be Offered to Elderly Patients Only!

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Is Equally Effective at All Ages!

Alcohol Septal Ablation Is the Choice for Most Cases!

Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? No, It Does Not!

Debate 1: Does Alcohol Septal Ablation Increase the Risk for Sudden Cardiac Death? Yes, Definitely!

HCM Ablation Step-by-Step Approach, Complications, and Long-term Outcomes

CTA for Procedure Planning

Indications for Septal Reduction Therapy

Medical Management: Agents and Effectiveness

Pathophysiology and Natural History

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Thoughtful Commentary on the Case

Severe Septal Bulge (± Hypertrophic Cardiomyopathy) and TAVR: Case Presentation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content